Kureha Kagaku Kogyo Kabushiki Kaisha

Minoru Ohhara

Kenichi Matsunaga

Takayoshi Fujii

Chikao Yoshikumi

Takao Ando

Masanori Ikuzawa

Fumio Hirose

Yoshio Ohmura

Disclosed is a pharmaceutical composition containing an aminobenzoic acid derivative as an active ingredient represented by the following general formula: ##STR1## wherein .sup.1 R donotes one member selected from the group consisting of the residual groups formed by removing OH at 1(alpha) or 1(beta) position from arabinose, glucose, galactose and mannose, or a pharmaceutically acceptable salt thereof.

Pharmaceutical compositions containing a derivative of para-aminobenzoic

Pharmaceutical composition containing a derivative of para-aminobenzoic

Disclosed is a method for the treatment of hyperglycemia, hyperlipemia, inflammatory diseases, pains due to the accentuation of central nerve, pyrexia due to the accentuation of central nerve or tumor, which comprises administering to a patient suffering therefrom a pharmaceutically effective amount of p-aminobenzoic acid-N-L-rhamnoside or a pharmaceutically acceptable salt thereof.

Method for the treatment of tumors

Disclosed is a pharmaceutical composition containing an aminobenzoic acid derivative as an active ingredient represented by the following general formula: ##STR1## wherein .sup.1 R denotes one member selected from the group consisting of the residual groups formed by removing OH at 1(alpha) or 1(beta) position from arabinose, xylose, glucose, galactose, rhamnose and mannose, and .sup.2 R denotes hydrogen or methyl group, or a pharmaceutically acceptable salt thereof.

Pharmaceutical composition containing a derivative of orthoaminobenzoic

P-aminobenzoic acid-N-L-rhamnoside pharmaceutical compositions for

Disclosed is a pharmaceutical composition containing p-aminobenzoic acid-N-L-rhamonoside or a pharmaceutically acceptable salt thereof as an active ingredient.

Pharmaceutical composition containing para-aminobenzoic

Method for the treatment of pains or pyrexia due to the accentuation of

Disclosed is a pharmaceutical composition containing an aminobenzoic acid derivative as an active ingredient represented by the following general formula: ##STR1## wherein .sup.1 R denotes one member selected from the group consisting of the residual groups formed by removing OH at 1(alpha) or 1(beta) position from arabinose, glucose, galactose and mannose, or a pharmaceutically acceptable salt thereof.

Method for the treatment of hyperglycemia, hyperlipemia, inflammatory

A pharmaceutical composition for regulating prostagrandins, which comprises (a) a derivative of aminobenzoic acid, represented by the following general formula: ##STR1## wherein R.sup.1 denotes one member selected from the group consisting of the residual groups formed by removing OH at 1(alpha)-or 1(beta) position from arabinose, xylose, rhamnose, glucose, galactose, mannose and fructose, and R.sup.2 is a hydrogen atom, an alkyl group of one to four carbon atoms or a pharmaceutically acceptable metal, and (b) a pharmaceutically acceptable carrier or diluent of (a) is disclosed.

Pharmaceutical composition comprising derivative of aminobenzoic acid

Disclosed is a pharmaceutical composition containing p-aminobenzoic acid-N-D-mannoside or a pharmaceutically acceptable salt thereof as an active ingredient.

Pharmaceutical composition containing para-amino-benzoic

The novel derivatives of saccharide obtained by bringing a saccharide into reaction with an ester of aminobenzoic acid, an aminobenzoic acid amide, an aminophenylacetic acid or an ester thereof have various physiological activities.

Growing community of inventors

Tokyo, Japan

Minoru Ohhara